PDEs as drug targets

Phosphodiesterases make good drug targets because they bind small ligands and share similar catalytic mechanisms, while displaying unique architectures around their active sites. This allows for the development of selective inhibitors.

Read more

PDE4NPD and the EU

The PDE4NPD Project is one of four neglected parasitic disease (NPD) projects funded under the auspices of the European Commission’s FP7 HEALTH programme.

Read more

Latest news

PDE4NPD at EFMC International Symposium on Medicinal Chemistry

Several members of the PDE4NPD consortium will be presenting at the XXIV EFMC International Symposium on Medicinal Chemistry, in Manchester, UK, from August 28 - September 1. Would you like to learn more about the PDE4NPD project? Visit our posters!

Read more